P2RX7 and Psoriasiform dermatitis: Notably, the ATP analog (BzATP), together with an E-NTPDases inhibitor, was able to initiate the development of a full psoriasiform response, which is eliminated by the treatment with anti-Ly6G antibody, highlighting the essential role of P2X7-activated neutrophils in the onset of psoriasiform dermatitis [76].